© 1992 Nature Publishing Group

© 1992 Nature Publishing Group

© 1992 Nature Publishing Group

© 1992 Nature Publishing Group

Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

The central pathological feature of human kidney disease that leads to kidney failure is the accumulation of extracellular matrix in glomeruli. Overex...
525KB Sizes 0 Downloads 0 Views
Download PDF

Recommend Documents

Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice.
Keap1 hypomorphism protects against ischemic and obstructive kidney disease.
Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
Transforming growth factor-β1 protects against intestinal epithelial barrier dysfunction caused by hypoxia-reoxygenation.
Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring.
Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta.
Specific calpain inhibition protects kidney against inflammaging.
Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model.
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.

Follow Us

Copyright © 2024 D.DOCKSCI.COM. All rights reserved. | Design by w3layouts